Search PubMed⌕ Search

Biomedical subjects

M D Prager

Publications and source records attributed to M D Prager.

60 records · Page 4Linked to original sources

Proteolytic activity in burn wound exudates and comparison of fibrin degradation products and protease inhibitors in exudates and sera.

Proteolytic (caseinolytic) activity in burn wound exudates was screened over the range pH 5.3 to 8.4. Although activity was greatest at pH 8.4 in four of seven exudates, individual differences indicated that different proteases predominate in the local environment of the wound. Paired exudate and serum samples were compared with regard to fibrin degradation products and three protease inhibitors: antithrombin III, a1-protease inhibitor, and a2-antiplasmin. Fibrin degradation products concentration was higher in exudates than in paired sera, indicating the wound as the source of circulating fibrin degradation products rather than intravascular coagulation followed by fibrinolysis. In contrast, all three protease inhibitors exhibited higher concentrations in serum than in the paired exudate. The serum/exudate ratio for AT III differed significantly from that for a1-protease inhibitor and a2-antiplasmin, and the ratio of two inhibitors in serum differed from the ratio of the same two inhibitors in the exudate in two of three comparisons. These findings emphasize the importance of exudate examinations as a reflection of events in the wound itself. The importance of microenvironments is invoked to account for the significant exudate fibrin degradation products titers, which are seen despite the presence of antithrombin III, which could inhibit coagulation, and the presence of a2-antiplasmin, which could inhibit fibrin degradation.

Burns↗

Syngeneic and allogeneic mouse lymphoma antisera: specificity, reaction with fetal antigen and protective capacity.

Vaccination with modified lymphoma cells produced highly specific antisera in syngeneic murine hosts. These were C3H/HeJ anti-6C3HED and BALB/cJ anti-P1798. These antisera gave positive membrane immunofluorescence tests with the corresponding tumor cells as well as with drug-resistant cells derived from the parental line. Immune BALB/cJ, but not immune C3H/HeJ, antiserum was cytotoxic in the presence of complement. The antisera did not cross-react with the opposite tumor, Moloney virus-induced YAC lymphoma cells, or normal splenocytes from either mouse strain. Both immune and nonimmune sera gave a positive cytotoxic test with Gross virus-induced lymphoma cells, indicating exposure of all the animals to the virus. Mice periodically given booster injections served repeatedly as serum donors; BALB/cJ mice not boosted for 42 weeks after tumor rejection still had circulating anti-P1798 antibodies. Allogeneic C57BL/KsJ anti-P1798 gave immunofluorescence tests with P1798, 6C3HED and normal BALB/cJ lymphocytes; it was cytotoxic for P1798 but not for normal lymphocytes. After absorption with normal BALB/cJ tissues, the serum became highly specific for P1798 but lost it cytotoxicity. Syngeneic and absorbed allogeneic anti-P1798 inhibited fetal liver colony formation on the spleens of irradiated BALB/c mice, indicating reaction with fetal antigen, but 6C3H/HeJ anti-6C3HED did not give similar inhibition. The latter antiserum was used successfully for passive immunization as long as there was excess antibody; BALB/c anti-P1798 did not protect, while C57BL/KsJ anti-P1798 was only marginally protective.

Animals↗